ALBT insider filings
Avalon GloboCare Corp. — 11 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-07-13. Screen ALBT transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 6 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Felix Lourdes — Director | 1 | — | — | 1 |
| Ingargiola Luisa — Chief Strategy Officer | 1 | — | — | 1 |
| Li Meng — Interim CEO | 1 | — | — | 1 |
| Lu Wenzhao — Director | 1 | — | — | 1 |
| Mathews Michael — Director | 1 | — | — | 1 |
| Sanders Steven Andrew — Director | 1 | — | — | 1 |
Recent insider filings — Avalon GloboCare Corp.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-13 | 4 | Lu Wenzhao — Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2026-07-13 | 4 | Li Meng — Interim CEO | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2026-07-13 | 4 | Felix Lourdes — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-07-13 | 4 | Mathews Michael — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-07-13 | 4 | Ingargiola Luisa — Chief Strategy Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2026-07-13 | 4 | Sanders Steven Andrew — Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Mathews Michael — Director | Grant/award (A): 1,364.84 (derivative) | EDGAR |
| 2023-03-09 | 4 | Sanders Steven Andrew — Director | Grant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2023-03-09 | 4 | Tauzin W J — Director | Grant/award (A): 4,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 · +1 more | EDGAR |
| 2023-03-08 | 4 | Stilley William B. III — Director | Grant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2023-03-08 | 4 | Troy Tevi — Director | Grant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Avalon GloboCare Corp.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-18 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-31 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-31 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2026-07-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
Registration filings — Avalon GloboCare Corp.
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-298153 (S-1) — latest: Amendment (S-1/A), filed 2026-09-16
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ALBT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →